AtaiBeckley
ATAI
7.35
0.00
0.00%
AtaiBeckley
US · ATAI
#2575 by market cap
Listed 2021
7.35
0.00
0.00%
Live - 5344 symbols - heartbeat 523s ago
· 2026-10-07 19:54
- Market cap
- 2.73B
- P/E (TTM)i
- -2.63
- P/Bi
- 15.44
- EPSi
- -2.91
- Div yieldi
- 0.00%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on ATAI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Institutional ownership
- Held by institutions
- 54.78% -0.81pp
- Institutions
- 271 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund25.26%
VC/PE Fund19.94%
Hedge Fund5.49%
Family Office/Trust2.36%
Individual/Insider2.29%
Public Company0.96%
Government Pension Fund0.22%
Endowment Fund0.19%
Private Company0.19%
Other43.11%
Top holders as of 2026-07-15
Apeiron Investment Group Limited
14.55% · 53.97M sh
BlackRock
6.90% · 25.57M sh
Deep Track Capital, LP
3.89% · 14.42M sh
Vanguard Capital Management, LLC
3.59% · 13.32M sh
Galaxy Group Investments LLC
2.28% · 8.47M sh
State Street Global Advisors
2.23% · 8.29M sh
Cosmo Mellen
2.07% · 7.66M sh
Geode Capital Management, LLC
1.87% · 6.93M sh
Adage Capital Management, L.P.
1.52% · 5.64M sh
UBS Asset Management
1.33% · 4.91M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 13 buys · 37 sells
| Name | Role | Stake |
|---|---|---|
| Apeiron Investment Group Limited | -- | 14.55% |
| Cosmo Mellen | Independent Non-Executive Director | 2.07% |
| Srinivas Rao | Co-Founder & CSO | 0.06% |
| Ryan Barrett | General Counsel | 0.04% |
| Anne Johnson | Chief Accounting Officer & Interim CFO | 0.04% |
| Florian Brand | Co-founder & CEO | 0.04% |
| Sahil Kirpekar | Chief Business Officer | 0.03% |
| Glenn Short | Former Senior Vice President of Early Development | 0.01% |
| Kevin Craig | Senior Vice President of Clinical Development | 0.00% |
| Andrea Smiley | Independent Member of Supervisory Board | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-10 | Sabrina Johnson | Independent Member of Supervisory Board | Derivative Sale to Issuer | -455,968 | -- |
| 2026-09-10 | Laurent Fischer | Independent Supervisory Director | Derivative Sale to Issuer | -430,968 | -- |
| 2026-09-10 | Robert Hershberg | Non-Executive Directors | Derivative Sale to Issuer | -741,089 | -- |
| 2026-09-10 | Michael Faerm | Chief Financial Officer | Derivative Sale to Issuer | -1,275,000 | -- |
| 2026-09-10 | Michael Faerm | Chief Financial Officer | Derivative Sale to Issuer | -285,000 | -- |
| 2026-09-10 | Amir Kalali | Independent Member of Supervisory Board | Sale to Issuer | -4,666 | -- |
| 2026-09-10 | Amir Kalali | Independent Member of Supervisory Board | Derivative Sale to Issuer | -455,968 | -- |
| 2026-09-10 | Srinivas Rao | Co-Founder & CSO | Sale to Issuer | -216,442 | -- |
| 2026-09-10 | Srinivas Rao | Co-Founder & CSO | Derivative Sale to Issuer | -9,521,381 | -- |
| 2026-09-10 | Srinivas Rao | Co-Founder & CSO | Derivative Sale to Issuer | -442,000 | -- |
| 2026-09-10 | Scott Braunstein | Independent Supervisory Director | Derivative Sale to Issuer | -573,881 | -- |
| 2026-09-10 | Apeiron Investment Group Limited | -- | Sale to Issuer | -55,756,748 | -- |
| 2026-09-10 | Apeiron Investment Group Limited | -- | Derivative Sale to Issuer | -2,310,528 | -- |
| 2026-09-10 | Andrea Smiley | Independent Member of Supervisory Board | Sale to Issuer | -4,666 | -- |
| 2026-09-10 | Andrea Smiley | Independent Member of Supervisory Board | Derivative Sale to Issuer | -455,968 | -- |
| 2026-09-10 | Ryan Barrett | General Counsel | Sale to Issuer | -155,066 | -- |
| 2026-09-10 | Ryan Barrett | General Counsel | Derivative Sale to Issuer | -3,493,267 | -- |
| 2026-09-10 | Ryan Barrett | General Counsel | Derivative Sale to Issuer | -150,000 | -- |
| 2026-09-10 | Glenn Short | Former Senior Vice President of Early Development | Sale to Issuer | -42,333 | -- |
| 2026-09-10 | Glenn Short | Former Senior Vice President of Early Development | Derivative Sale to Issuer | -2,935,367 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.